Testing effectiveness (Phase 2)Study completedNCT01153932
What this trial is testing
Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy
Who this might be right for
Muscular Dystrophies
GlaxoSmithKline 53